Lifecore Biomedical
LFCR
LFCR
95 hedge funds and large institutions have $334M invested in Lifecore Biomedical in 2017 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 29 increasing their positions, 32 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
11% less capital invested
Capital invested by funds: $376M → $334M (-$41.8M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
95
Holding in Top 10
1
Calls
$220K
Puts
–
Top Buyers
| 1 | +$8.26M | |
| 2 | +$1.44M | |
| 3 | +$687K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$421K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$400K |
Top Sellers
| 1 | -$1.82M | |
| 2 | -$1.47M | |
| 3 | -$1M | |
| 4 |
GIP
Granite Investment Partners
El Segundo,
California
|
-$821K |
| 5 |
CAM
Congress Asset Management
Boston,
Massachusetts
|
-$786K |